Munich, Germany

Hans Schubel

This inventor holds 1 USPTO granted patent. Top assignee: Dynamit Nobel Aktiengesellschaft. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Schubel

Introduction

Hans Schubel is a notable inventor based in Munich, Germany. He has made significant contributions to the field of chemistry, particularly in the synthesis of optically active compounds. His work has implications in various applications, including pharmaceuticals.

Latest Patents

Hans Schubel holds a patent for a process titled "Process for obtaining D(-)-and L(+)-α-azidophenylacetic acid." This innovative process involves reacting a water-soluble salt of DL-α-azidophenylacetic acid with a water-soluble salt of an optically active α-phenylethylamine in an aqueous medium. The method effectively crystallizes the resulting reaction product, which is the diastereomeric salt, and facilitates the splitting of the obtained salt. This patent showcases his expertise in chemical processes and his ability to create valuable compounds.

Career Highlights

Hans Schubel is associated with Dynamit Nobel Aktiengesellschaft, a company known for its advancements in chemical manufacturing and technology. His role at the company has allowed him to work on innovative projects that push the boundaries of chemical research. With a total of 1 patent, he has established himself as a key figure in his field.

Collaborations

Throughout his career, Hans has collaborated with esteemed colleagues such as Gunter Bison and Gerhard Schmeling. These partnerships have fostered an environment of innovation and have contributed to the success of various projects.

Conclusion

Hans Schubel's contributions to the field of chemistry through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…